IGF1R and breast cancer: DDR1 silencing was accompanied by a reduction of IGF-IR protein levels in all three breast cancer cell lines tested (Figure 7a) while DDR1 overexpression was associated with enhanced IGF-IR levels, which were especially marked in MCF-7 and MDA-MB-231 cells (Figure 7b).